NO921495D0 - Oligosakkarid og fremgangsmaate for dets fremstilling - Google Patents
Oligosakkarid og fremgangsmaate for dets fremstillingInfo
- Publication number
- NO921495D0 NO921495D0 NO921495A NO921495A NO921495D0 NO 921495 D0 NO921495 D0 NO 921495D0 NO 921495 A NO921495 A NO 921495A NO 921495 A NO921495 A NO 921495A NO 921495 D0 NO921495 D0 NO 921495D0
- Authority
- NO
- Norway
- Prior art keywords
- oligosaccarid
- procedure
- preparation
- oligosaccharide
- sulfate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
- C07H5/08—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to sulfur, selenium or tellurium
- C07H5/10—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to sulfur, selenium or tellurium to sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
- C08B37/0078—Degradation products
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Materials Engineering (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Polymers & Plastics (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11090591 | 1991-04-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO921495D0 true NO921495D0 (no) | 1992-04-15 |
NO921495L NO921495L (no) | 1992-10-19 |
Family
ID=14547637
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO92921495A NO921495L (no) | 1991-04-16 | 1992-04-15 | Oligosakkarid og fremgangsmaate for dets fremstilling |
Country Status (11)
Country | Link |
---|---|
US (1) | US5849722A (no) |
EP (1) | EP0509517B1 (no) |
KR (1) | KR920019810A (no) |
AT (1) | ATE148470T1 (no) |
AU (1) | AU656953B2 (no) |
CA (1) | CA2066305A1 (no) |
DE (1) | DE69217104T2 (no) |
FI (1) | FI921689A (no) |
MX (1) | MX9201801A (no) |
NO (1) | NO921495L (no) |
ZA (1) | ZA922830B (no) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5610148A (en) * | 1991-01-18 | 1997-03-11 | University College London | Macroscopically oriented cell adhesion protein for wound treatment |
US5629287A (en) * | 1991-01-18 | 1997-05-13 | University College London | Depot formulations |
GB9206291D0 (en) * | 1992-03-23 | 1992-05-06 | Cancer Res Campaign Tech | Oligosaccharides having growth factor binding affinity |
WO1994020512A2 (en) * | 1993-03-01 | 1994-09-15 | Glycan Pharmaceuticals, Inc. | Analogs for specific oligosaccharide-protein interactions and uses therefor |
GB9306255D0 (en) * | 1993-03-25 | 1993-05-19 | Cancer Res Campaign Tech | Heparan sulphate oligosaccharides having hepatocyte growth factor binding affinity |
US6140481A (en) * | 1994-07-01 | 2000-10-31 | Seikagaku Corporation | Process for producing desulfated polysaccharide, and desulfated heparin |
GB9722604D0 (en) * | 1997-10-28 | 1997-12-24 | Cancer Res Campaign Tech | Heparin-binding growth factor derivatives |
JP4262979B2 (ja) * | 2000-11-21 | 2009-05-13 | ザ・テキサス・エイ・アンド・エム・ユニバーシテイ・システム | Fgfアフィニティークロマトグラフィー |
WO2002076475A2 (en) * | 2001-03-23 | 2002-10-03 | Bioparken As | Glycosaminoglycan anticoagulants derived from fish |
CH696701A5 (de) * | 2001-12-18 | 2007-10-15 | Hoffmann La Roche | Verfahren zum Testen eines Mittels auf dessen Fähigkeit, die Heparanaseaktivität zu hemmen. |
US20060183712A1 (en) * | 2005-02-17 | 2006-08-17 | The Texas A&M University System | Affinity purified heparin/heparan sulfate for controlling the biological activity of the FGF receptor |
JP6070693B2 (ja) * | 2012-03-30 | 2017-02-01 | 味の素株式会社 | 硫酸化化合物を含む幹細胞増殖用培地 |
JP6321786B2 (ja) | 2013-05-16 | 2018-05-09 | エージェンシー フォー サイエンス,テクノロジー アンド リサーチ | ヘパラン硫酸 |
US10493012B2 (en) | 2014-11-19 | 2019-12-03 | Agency For Science, Technology And Research | Cosmetic use of heparan sulphate |
SG11201704085QA (en) | 2014-11-19 | 2017-06-29 | Agency Science Tech & Res | Heparan sulphates for use in repair and/or regeneration of skin |
CN104530262B (zh) * | 2015-01-26 | 2016-08-24 | 安徽科宝生物工程有限公司 | 一种从猪肺中提取肝素的生产方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1136620A (en) * | 1979-01-08 | 1982-11-30 | Ulf P.F. Lindahl | Heparin fragments having selective anticoagulation activity |
US4785079A (en) * | 1984-11-09 | 1988-11-15 | The Salk Institute For Biological Studies | Isolation of fibroblast growth factor |
US4916219A (en) * | 1985-03-28 | 1990-04-10 | University Of Iowa Research Foundation | Oligosaccharide heparin fragments as inhibitors of complement cascade |
FR2597484B1 (fr) * | 1986-04-17 | 1988-12-23 | Sanofi Sa | Glycosaminoglycanes de type heparine ou heparane-sulfate dotes d'une activite sur la division et la differentiation cellulaires, leur preparation et leurs applications therapeutiques. |
US4788307A (en) * | 1986-04-30 | 1988-11-29 | Choay S.A. | Oligosaccharidic fractions devoid or practically devoid of antithrombotic activity |
FR2614026B1 (fr) * | 1987-04-16 | 1992-04-17 | Sanofi Sa | Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques |
US5100668A (en) * | 1988-06-14 | 1992-03-31 | Massachusetts Institute Of Technology | Controlled release systems containing heparin and growth factors |
JPH0240399A (ja) * | 1988-07-27 | 1990-02-09 | Takeda Chem Ind Ltd | 線維芽細胞増殖因子ムテインの複合体あるいは組成物 |
US5175147A (en) * | 1988-08-19 | 1992-12-29 | Takeda Chemical Industries, Ltd | Acid-resistant fgf composition and method of treating ulcerating diseases of the gastrointestinal tract |
PT93847A (pt) * | 1989-04-24 | 1990-11-20 | Harvard College | Processo para a preparacao de oligossacaridos de baixo peso molecular derivados de heparina ou de sulfato de heparano despolimerizados e de composicoes farmaceuticas que os contem |
US5126323A (en) * | 1989-11-16 | 1992-06-30 | Genetics Institute, Inc. | Homogeneous purified k-fgf and compositions containing the same |
-
1992
- 1992-04-15 NO NO92921495A patent/NO921495L/no unknown
- 1992-04-15 FI FI921689A patent/FI921689A/fi not_active Application Discontinuation
- 1992-04-15 MX MX9201801A patent/MX9201801A/es unknown
- 1992-04-16 DE DE69217104T patent/DE69217104T2/de not_active Expired - Fee Related
- 1992-04-16 ZA ZA922830A patent/ZA922830B/xx unknown
- 1992-04-16 KR KR1019920006345A patent/KR920019810A/ko not_active Application Discontinuation
- 1992-04-16 AT AT92106645T patent/ATE148470T1/de not_active IP Right Cessation
- 1992-04-16 AU AU15003/92A patent/AU656953B2/en not_active Ceased
- 1992-04-16 CA CA002066305A patent/CA2066305A1/en not_active Abandoned
- 1992-04-16 EP EP92106645A patent/EP0509517B1/en not_active Expired - Lifetime
-
1995
- 1995-06-06 US US08/471,174 patent/US5849722A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0509517A3 (en) | 1993-09-01 |
MX9201801A (es) | 1992-10-30 |
ZA922830B (en) | 1993-01-27 |
NO921495L (no) | 1992-10-19 |
US5849722A (en) | 1998-12-15 |
ATE148470T1 (de) | 1997-02-15 |
DE69217104D1 (de) | 1997-03-13 |
EP0509517B1 (en) | 1997-01-29 |
AU1500392A (en) | 1993-03-11 |
FI921689A0 (fi) | 1992-04-15 |
KR920019810A (ko) | 1992-11-20 |
EP0509517A2 (en) | 1992-10-21 |
DE69217104T2 (de) | 1997-06-05 |
FI921689A (fi) | 1992-10-17 |
CA2066305A1 (en) | 1992-10-17 |
AU656953B2 (en) | 1995-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO921495L (no) | Oligosakkarid og fremgangsmaate for dets fremstilling | |
KR970003057B1 (en) | Lyophilized pharmaceutical composition of neocarzinostatin derivative | |
ZA893882B (en) | New heparin derivatives and process for their preparation | |
GB2249315B (en) | A process for producing an aqueous solution of sodium hyaluronate | |
IL84177A (en) | Process for the manufacture of alginates and other uronic acid compounds with altered physical properties | |
GB8806737D0 (en) | Therapeutic composition & method | |
HUT53871A (en) | Process for producing 1,4-disubstituted piperidinyldiketone derivatives | |
HUT62315A (en) | Process for producing agent promoting hepatocyte growth | |
HU907113D0 (en) | Process for producing analogues of 2', 3'-didesoxy-2'-fluoro-arabino-nucleoside | |
HUT51300A (en) | Process for producing substituted alkylamide derivatives of teicoplanin compounds | |
HUT57724A (en) | Process for producing dialkyl-(2,3-pyridinedicarboxylate) and its derivatives | |
HUT59600A (en) | Process for producing pharmaceutical compositions containing 5-methyl-isoxazoe-4-carboxylik-anilides or alpha-/2-hydroxy-ethylidene/-alpha-cyano-acetic-anilides for treating eye-diseases | |
CA2073292A1 (en) | Carboxyalkyl polysaccharides having improved absorbent properties and process for the preparation thereof | |
DE69027157D1 (de) | Verfahren zur Herstellung eines Süssstoffes auf Grund des Aspartams, die in einer trockenen knollenähnlichen Form ist | |
DE3569075D1 (en) | Method and compositions for use in the treatment of fireblight | |
CS472690A3 (en) | Combination preparation with antithrombotic effect | |
IL89242A (en) | Process for producing a recombinant microorganism capable of converting glucose into 2-keto-l-gulonic acid,the microorganism obtained by said process and its use in converting glucose into 2-keto-l-gulonic acid | |
HU9200900D0 (en) | Process for the production of cyclic peroxi-acethale-lacton, -lactol and ether derivatives | |
GR3008746T3 (no) | ||
HUT60509A (en) | Process for producing monomer and 125 i-marked derivatives of t-butyloxycarbonyl-l-tyrosylpeptidoglycan | |
AU624690B2 (en) | A mutant of microbacterium, a strain 851r, and a process for producing 851 nutrient solution by application of the strain | |
HUT44802A (en) | Process for producing pseudo-oligosaccharides and pharmaceutical compositions containing them | |
ZA882762B (en) | Novel derivative of d.25,process for its preparation,its use as an immunostimulant,and pharmaceutical compositions containing the derivative | |
KR900001723A (ko) | 저분자량의 소디윰알긴네이트의 제조방법 및 고흡수성 지혈대 | |
ITPD920205A1 (it) | Acilazione selettiva del gruppo 6-idrossile dei residui n-acetilglucosamina dei derivati dell'acido ialuronico |